Polo‑like kinase 4 is associated with advanced TNM stages and reduced survival and its inhibition improves chemosensitivity in colorectal cancerZhengang Duan(People 's Liberation Army 451 Hospital), Wei Wu(Xi'an Jiaotong University)Oncology LettersJune 20, 202210.3892/ol.2022.13389Cited by 9SaveCiteExport RISWatch citationsRelated PapersHippo pathway activation mediates chemotherapy-induced anti-cancer effect and cardiomyopathy through causing mitochondrial damage and dysfunction|Theranostics|2023|61Case Report: Hemophagocytic Lymphocytosis in a Patient With Glutaric Aciduria Type IIC|Frontiers in Immunology|2022|7